[go: up one dir, main page]

BR112017005764A2 - apoio à decisão para pacientes com diabetes - Google Patents

apoio à decisão para pacientes com diabetes

Info

Publication number
BR112017005764A2
BR112017005764A2 BR112017005764A BR112017005764A BR112017005764A2 BR 112017005764 A2 BR112017005764 A2 BR 112017005764A2 BR 112017005764 A BR112017005764 A BR 112017005764A BR 112017005764 A BR112017005764 A BR 112017005764A BR 112017005764 A2 BR112017005764 A2 BR 112017005764A2
Authority
BR
Brazil
Prior art keywords
profile
insulin
patient
adjustment
basal
Prior art date
Application number
BR112017005764A
Other languages
English (en)
Inventor
Capurro Jorge
Mccann Thomas
Schaible Thomas
Original Assignee
Animas Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Animas Corp filed Critical Animas Corp
Publication of BR112017005764A2 publication Critical patent/BR112017005764A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • A61M2005/1726—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure the body parameters being measured at, or proximate to, the infusion site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3553—Range remote, e.g. between patient's home and doctor's office
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3569—Range sublocal, e.g. between console and disposable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3584—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using modem, internet or bluetooth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Medical Informatics (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

a presente invenção refere-se a um sistema de apoio à decisão que inclui um dispositivo de medição configurado para medir continuamente um parâmetro fisiológico de um paciente. um dispositivo de liberação de insulina fornece insulina ao paciente de acordo com um perfil basal inicial e as medições do parâmetro. um dispositivo de armazenamento contém dados históricos de liberação de insulina ao paciente. um processador determina os desvios da liberação de insulina em relação ao perfil basal para um ou mais período(s) de tempo usando os dados históricos, calcula um respectivo primeiro ajuste do perfil basal para cada um do um ou mais período(s) de tempo usando os desvios determinados, e anuncia o(s) primeiro(s) ajuste(s) do perfil basal calculado. um método para recomendar um ajuste da taxa basal inclui medir o parâmetro, infundir o paciente com insulina e armazenar os dados históricos, determinar dos desvios do perfil basal, calcular os primeiros ajustes do perfil basal, e anunciar o(s) primeiro(s) ajuste(s) do perfil basal.
BR112017005764A 2014-09-23 2015-09-18 apoio à decisão para pacientes com diabetes BR112017005764A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/494,018 US20160082187A1 (en) 2014-09-23 2014-09-23 Decisions support for patients with diabetes
PCT/US2015/050919 WO2016048823A1 (en) 2014-09-23 2015-09-18 Decisions support for patients with diabetes

Publications (1)

Publication Number Publication Date
BR112017005764A2 true BR112017005764A2 (pt) 2017-12-12

Family

ID=55524783

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017005764A BR112017005764A2 (pt) 2014-09-23 2015-09-18 apoio à decisão para pacientes com diabetes

Country Status (10)

Country Link
US (1) US20160082187A1 (pt)
JP (1) JP2017532113A (pt)
KR (1) KR20170057405A (pt)
CN (1) CN107135644A (pt)
AU (1) AU2015321711A1 (pt)
BR (1) BR112017005764A2 (pt)
CA (1) CA2961887A1 (pt)
RU (1) RU2017113941A (pt)
TW (1) TW201619906A (pt)
WO (1) WO2016048823A1 (pt)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US10852069B2 (en) 2010-05-04 2020-12-01 Fractal Heatsink Technologies, LLC System and method for maintaining efficiency of a fractal heat sink
US20110313680A1 (en) * 2010-06-22 2011-12-22 Doyle Iii Francis J Health Monitoring System
US9561324B2 (en) 2013-07-19 2017-02-07 Bigfoot Biomedical, Inc. Infusion pump system and method
US10569015B2 (en) 2013-12-02 2020-02-25 Bigfoot Biomedical, Inc. Infusion pump system and method
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
CA2977053C (en) 2015-02-18 2023-08-01 Insulet Corporation Fluid delivery and infusion devices, and methods of use thereof
US9878097B2 (en) 2015-04-29 2018-01-30 Bigfoot Biomedical, Inc. Operating an infusion pump system
US10449294B1 (en) 2016-01-05 2019-10-22 Bigfoot Biomedical, Inc. Operating an infusion pump system
AU2016385454B2 (en) 2016-01-05 2021-12-16 Bigfoot Biomedical, Inc. Operating multi-modal medicine delivery systems
WO2017123525A1 (en) 2016-01-13 2017-07-20 Bigfoot Biomedical, Inc. User interface for diabetes management system
AU2017207484B2 (en) 2016-01-14 2021-05-13 Bigfoot Biomedical, Inc. Adjusting insulin delivery rates
US10610643B2 (en) 2016-01-14 2020-04-07 Bigfoot Biomedical, Inc. Occlusion resolution in medication delivery devices, systems, and methods
EP3408774B1 (en) 2016-01-29 2023-09-27 University of Virginia Patent Foundation d/b/a University of Virginia Licensing & Ventures Group Method, system, and computer readable medium for virtualization of a continuous glucose monitoring trace
EP3479267B1 (en) * 2016-06-30 2020-05-27 Novo Nordisk A/S Regimen adherence measure for insulin treatment based on glucose measurements and insulin pen data
CN109564776B (zh) * 2016-08-17 2023-09-26 诺和诺德股份有限公司 用于调整胰岛素方案中的基础/餐时比率的系统和方法
WO2018058041A1 (en) 2016-09-23 2018-03-29 Insulet Corporation Fluid delivery device with sensor
WO2018111928A1 (en) 2016-12-12 2018-06-21 Mazlish Bryan Alarms and alerts for medication delivery devices and related systems and methods
US10854324B2 (en) * 2016-12-21 2020-12-01 Medtronic Minimed, Inc. Infusion systems and methods for prospective closed-loop adjustments
US10758675B2 (en) 2017-01-13 2020-09-01 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US11033682B2 (en) 2017-01-13 2021-06-15 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US10500334B2 (en) 2017-01-13 2019-12-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
US10583250B2 (en) 2017-01-13 2020-03-10 Bigfoot Biomedical, Inc. System and method for adjusting insulin delivery
WO2018132754A1 (en) 2017-01-13 2018-07-19 Mazlish Bryan System and method for adjusting insulin delivery
US10610644B2 (en) 2017-01-13 2020-04-07 Bigfoot Biomedical, Inc. Insulin delivery methods, systems and devices
US20210142879A1 (en) * 2017-02-23 2021-05-13 Novo Nordisk A/S Systems and methods for communicating a dose
WO2018167543A1 (en) * 2017-03-17 2018-09-20 Universität Bern System and method for drug therapy management
CN107715230B (zh) * 2017-10-12 2019-10-01 微泰医疗器械(杭州)有限公司 基于云端大数据的胰岛素泵个体化配置优化系统
CN107788994B (zh) 2017-10-12 2019-10-01 微泰医疗器械(杭州)有限公司 一种基于云端大数据的智能实时动态血糖监测系统及方法
TWI678630B (zh) * 2018-01-16 2019-12-01 中央研究院 非侵入式估測hba1c與血糖值之系統與方法
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
US11007319B2 (en) * 2018-04-03 2021-05-18 Eoflow Inc. Systems and methods for managing diabetes
WO2019213493A1 (en) 2018-05-04 2019-11-07 Insulet Corporation Safety constraints for a control algorithm-based drug delivery system
FR3081315B1 (fr) 2018-05-22 2022-12-02 Commissariat Energie Atomique Systeme automatise de controle de la glycemie d'un patient
AU2019347755B2 (en) 2018-09-28 2023-02-02 Insulet Corporation Activity mode for artificial pancreas system
US11565039B2 (en) 2018-10-11 2023-01-31 Insulet Corporation Event detection for drug delivery system
USD920343S1 (en) 2019-01-09 2021-05-25 Bigfoot Biomedical, Inc. Display screen or portion thereof with graphical user interface associated with insulin delivery
WO2020153423A1 (ja) * 2019-01-23 2020-07-30 国立研究開発法人科学技術振興機構 投薬量管理支援システム
CN111939386B (zh) * 2019-05-17 2023-05-09 上海移宇科技股份有限公司 双边驱动的多输注模式药物输注装置
JP7599439B2 (ja) * 2019-06-05 2024-12-13 サノフイ 基礎インスリン用量およびボーラスインスリン用量を投与する医療デバイスおよび方法
US20220218895A1 (en) * 2019-08-01 2022-07-14 Medtrum Technologies Inc. Driving apparatus and drug infusion device
EP4013297A4 (en) 2019-08-16 2023-12-13 Poltorak Technologies, LLC DEVICE AND METHOD FOR MEDICAL DIAGNOSIS
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11213623B2 (en) * 2019-09-20 2022-01-04 Medtronic Minimed, Inc. Infusion systems and related personalized bolusing methods
US11241537B2 (en) * 2019-09-20 2022-02-08 Medtronic Minimed, Inc. Contextual personalized closed-loop adjustment methods and systems
MX2022003642A (es) * 2019-09-25 2022-07-12 Janssen Pharmaceuticals Inc Medicion de parámetros asociados con administracion de fármaco y dispositivos de administración de fármacos que los incorporan.
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
EP4354455A3 (en) 2019-12-06 2024-07-10 Insulet Corporation Techniques and devices providing adaptivity and personalization in diabetes treatment
WO2021126985A1 (en) * 2019-12-18 2021-06-24 Dexcom, Inc. Therapeutic zone assessor
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
WO2021141941A1 (en) 2020-01-06 2021-07-15 Insulet Corporation Prediction of meal and/or exercise events based on persistent residuals
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11986630B2 (en) 2020-02-12 2024-05-21 Insulet Corporation Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US11872034B2 (en) * 2020-02-20 2024-01-16 Dexcom, Inc. Machine learning in an artificial pancreas
WO2021178307A1 (en) * 2020-03-02 2021-09-10 Dexcom, Inc. Evaluation of data to provide decision support for a ketogenic lifestyle
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
EP4185348A1 (en) 2020-07-22 2023-05-31 Insulet Corporation Open-loop insulin delivery basal parameters based on insulin delivery records
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
WO2022072332A1 (en) 2020-09-30 2022-04-07 Insulet Corporation Drug delivery device with integrated optical-based glucose monitor
WO2022072618A1 (en) 2020-09-30 2022-04-07 Insulet Corporation Secure wireless communications between a glucose monitor and other devices
US20220168505A1 (en) * 2020-11-30 2022-06-02 Insulet Corporation Device and methods for a simple meal announcement for automatic drug delivery system
US11160925B1 (en) 2021-01-29 2021-11-02 Insulet Corporation Automatic drug delivery system for delivery of a GLP-1 therapeutic
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
KR102538332B1 (ko) * 2021-07-28 2023-05-31 순천향대학교 산학협력단 Imd 기반 인공 췌장 시스템을 위한 명세 기반의 오동작 탐지 시스템 및 그 방법
US20230062884A1 (en) * 2021-08-31 2023-03-02 Insulet Corporation Devices and methods for controlling drug dosage delivery for automatically providing a drug to a patient
US11738144B2 (en) 2021-09-27 2023-08-29 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery
AU2023421619A1 (en) 2023-01-06 2025-06-19 Insulet Corporation Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5251126A (en) * 1990-10-29 1993-10-05 Miles Inc. Diabetes data analysis and interpretation method
US9056165B2 (en) * 2006-09-06 2015-06-16 Medtronic Minimed, Inc. Intelligent therapy recommendation algorithm and method of using the same
US8732188B2 (en) * 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
WO2009075925A1 (en) * 2007-12-13 2009-06-18 Shaya Steven A Method and apparatus to calculate diabetic sensitivity factors affecting blood glucose
ES2888427T3 (es) * 2009-07-23 2022-01-04 Abbott Diabetes Care Inc Gestión en tiempo real de los datos relativos al control fisiológico de los niveles de glucosa
US8706691B2 (en) * 2012-07-24 2014-04-22 Roche Diagnostics Operations, Inc. System for managing insulin dosage data
US9592002B2 (en) * 2012-09-21 2017-03-14 Lifescan, Inc. Method and system to derive multiple glycemic patterns from glucose measurements during time of the day
US9795737B2 (en) * 2013-03-15 2017-10-24 Animas Corporation Method and system for closed-loop control of an artificial pancreas

Also Published As

Publication number Publication date
CN107135644A (zh) 2017-09-05
WO2016048823A1 (en) 2016-03-31
CA2961887A1 (en) 2016-03-31
RU2017113941A (ru) 2018-10-24
AU2015321711A1 (en) 2017-04-06
TW201619906A (zh) 2016-06-01
US20160082187A1 (en) 2016-03-24
KR20170057405A (ko) 2017-05-24
JP2017532113A (ja) 2017-11-02

Similar Documents

Publication Publication Date Title
BR112017005764A2 (pt) apoio à decisão para pacientes com diabetes
CY1121941T1 (el) Συστημα χορηγησης θεραπευτικου αεριου
WO2017209903A8 (en) Control-to-range failsafes
BR112017011813A8 (pt) Sistema de monitoramento de inalação e aparelho de entrega de medicamento
MX2018014680A (es) Agresividad de control a intervalo.
HK1207916A1 (zh) 醫療系統
BR112018005787A2 (pt) sistema, dispositivo eletrônico de fornecimento de aerossol, método para operar um sistema, dispositivo de computação, método para operar um dispositivo de computação e produto de programa de computador
HK1222349A1 (zh) 胰島素管理
HK1252606A1 (zh) 患者特異性劑量的系統和方法
MX2016006252A (es) Tratamiento o prevencion de afecciones pulmonares con monoxido de carbono.
BR112017019001A2 (pt) avaliação dependente do tempo de dados de sensor para determinar a estabilidade, fluência e elementos viscoelásticos de medidas
MX386688B (es) Sistemas y metodos para compensar a largo plazo la sensibilidad de la deriva de sensores electroquimicos de gas expuestos a oxido nitrico.
BR112017002470A2 (pt) sistemas e dispositivos de monitoramento de integridade de nervo sem fio
BR112022005657A2 (pt) Dispositivo de distribuição de fármaco
WO2014179594A3 (en) System and method for monitoring administration of nutrition
BR112013028858A2 (pt) dispositivo para facilitar a administração de fármaco com dispositivos a base de seringa, sistema para facilitar e gerenciar dados de administração de fármaco a partir de uma pluralidade de dispositivos de administração de fármaco a base de seringa, método para otimizar administração de fármaco com um dispositivo de administração de fármaco a base de seringa com o sistema
BR112016019529A8 (pt) Método implementado por computador e sistema para rastreamento do olhar dos olhos de um usuário
BR112017022875A2 (pt) sistema e método para controlar a administração de um medicamento a um paciente, e produto de software
BR112015027510A2 (pt) sistemas, métodos e aparelhos de controle e de monitoramento de aplicação
BR112016015549A2 (pt) Sistema de monitoramento médico, método para ajustar alarmes médicos, mídia de armazenamento legível por computador não transitória, e, dispositivo de processamento de dados eletrônicos
MX2020001369A (es) Sistema de analisis para el cuidado de un paciente.
WO2016005586A3 (en) Titration of basal insulin with two modes
EP3395385A4 (en) MEDICINAL INFUSION DEVICE, CARTRIDGE ADAPTER AND MEDICINAL INFUSION SYSTEM
BR112016002598A2 (pt) método para tratamento da diabetes mellitus, método para atualizar o regime de dosagem de insulina de um paciente, dispositivo e sistema para aliviar glicotoxicidade e/ou restabelecer a função das células beta pancreáticas em um paciente
BR112019020316A2 (pt) manutenção de limites máximos de dosagem para sistemas de administração de insulina em circuito fechado

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]